Daniel E. Spratt

Artificial intelligence applications in prostate cancer

2023 · 67 Zit. · Prostate Cancer and Prostatic Diseases

Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials

2024 · 9 Zit. · European Urology

Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials

2025 · 3 Zit. · JCO Clinical Cancer Informatics

Multimodal artificial intelligence (MMAI) model to identify benefit from 2nd-generation androgen receptor pathway inhibitors (ARPI) in high-risk non-metastatic prostate cancer patients from STAMPEDE.

2025 · 0 Zit. · Journal of Clinical Oncology

Evaluating the Correlation between Genomic Classifier and Digital Pathology-Based Multi-Modal AI Biomarkers in Localized Prostate Cancer

2025 · 0 Zit. · International Journal of Radiation Oncology*Biology*Physics